Latest News

Lupin unveils first generic version of Oracea in US
Mumbai: Global pharma major Lupin Limited has announced the
launch…

Pioglitazone add-on therapy in patients with type 2 diabetes effective and safe option for better glycemic control: Study
South Korea: Adjunctive pioglitazone therapy in type 2 diabetes…

MR Study sheds light on anti-inflammatory effects of SGLT-2 inhibitors and their beneficial impact in reducing HF risk
China: A two-sample Mendelian randomization (MR) study provides…

Stopping aspirin one month after PCI significantly reduces bleeding complications in patients with MI: Lancet
Withdrawing aspirin one month after percutaneous coronary intervention…

Adjuvant HBOT is beneficial in treating patients with pyoderma gangrenosum: Study
Brazil: A recent study has revealed that adjuvant hyperbaric…

Experimental drug Olezarsen may reduce hypertriglyceridemia in high-risk patients: NEJM
Hypertriglyceridemia, or high levels of lipids (fats) in the…
Facebook Comments